Eli Lilly releases more data on new obesity drug, heading for accelerated approval – NPR

Leave a Comment / Business / By
  1. Eli Lilly releases more data on new obesity drug, heading for accelerated approvalNPR
  2. Powerful new obesity drug set to boost weight loss careThe Associated Press
  3. People with diabetes lose up to 34 pounds while taking the drug Eli Lilly, the company saysBNC News
  4. Lilly’s Tirzepatide Achieved Up to 15.7% Weight Loss in Obese or Overweight Adults with Type 2 Diabetes in SURMOUNT-2 | Eli Lilly and companyInvestors | Eli Lilly and company
  5. Blood sugar drug tirzepatide also causes substantial weight loss in diabetic patients, says Eli LillyCNN

Leave a Comment

Your email address will not be published. Required fields are marked *